Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

CT-868

A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Carmot Therapeutics, Inc · Phase 2 · Completed · Enrollment 103

NCT05110846

ArmPopulationDoseWeeksEstimandWeight change
PlaceboObesity + T2Dn/r26n/rn/r
CT-868 1.75 mgObesity + T2D1.75 mg26n/rn/r
CT-868 4.0 mgObesity + T2D4.0 mg26n/rn/r